Glyburide Tablet
Product Images NDC 62135-583

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 62135-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Sublingual Tablets 2 mg (NDC 72888-182-30)

Buprenorphine Sublingual Tablets 2 mg (NDC 72888-182-30)
This is a description of a medication called GlyBURIDE that consists of 30 tablets for prescription use only. It includes an NDC code of 62135-583-30. Apart from that, the given text includes a series of seemingly unrelated letters, numbers and words that do not make sense and might be a result of errors.*
FDA Label Image

Buprenorphine Sublingual Tablets 2 mg (NDC 72888-182-90)

Buprenorphine Sublingual Tablets 2 mg (NDC 72888-182-90)
Glyburide is a prescription drug in the form of tablets that comes in a bottle of 30 tablets. The text contains several gibberish characters and codes that are not readable.*
FDA Label Image

Buprenorphine Sublingual Tablets 8 mg (NDC 72888-183-30)

Buprenorphine Sublingual Tablets 8 mg (NDC 72888-183-30)
This is a prescription for 90 tablets of GlyBURIDE, a USP medicine. The other text appears to be garbled or unreadable.*
FDA Label Image

Image Description (Glyburide Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.